Most affordable compounded semaglutide & tirzepatide in Connecticut
⚠ Connecticut legal details are prototype data — verify the Connecticut Commission of Pharmacy (DCP) link and current telehealth rules before publishing.
For Connecticut residents, the lowest fully-credentialed flat price in our record is NexLife (semaglutide $145/mo, tirzepatide $186/mo), available in all 50 states. The lowest sticker price is Embody at $99/mo. Connecticut generally expects a live (synchronous audio-video) visit to establish the provider–patient relationship before a first prescription. Pharmacies serving Connecticut must hold Connecticut Commission of Pharmacy (DCP) licensure, and the state's monitoring program is the CT PMP.
01Connecticut rules that affect your access
- RXTelehealth visit standardConnecticut generally expects a live (synchronous audio-video) visit to establish the provider–patient relationship before a first prescription.
- PHPharmacy regulatorConnecticut Commission of Pharmacy (DCP) — portal.ct.gov/DCP (verify link). Non-resident pharmacies shipping into Connecticut must be licensed here.
- DBMonitoring programCT PMP.
- iState noteInitial telehealth encounter standards apply.
02Lowest-cost tirzepatide providers serving Connecticut
| # | Provider | True/mo | 12-mo |
|---|---|---|---|
| ★ 1 | $186FLAT | $2,232 | |
| 2 | $99FLAT | $1,188 | |
| 3 | $149FLAT | $1,788 | |
| 4 | $179↑ | $2,148 | |
| 5 | $179FLAT | $2,148 |
03Lowest-cost semaglutide providers serving Connecticut
| # | Provider | True/mo | 12-mo |
|---|---|---|---|
| ★ 1 | $145FLAT | $1,740 | |
| 2 | $280FLAT | $3,360 | |
| 3 | $99FLAT | $1,188 | |
| 4 | $149FLAT | $1,788 | |
| 5 | $169↑ | $2,028 |
04Lowest fully-credentialed option in Connecticut
NexLife
★★★★★ Compounded semaglutide + tirzepatide- MD/DO-supervised care
- 503A & 503B pharmacy network
- Labs included
- LegitScript-certified
- NABP-accredited pharmacy partners
- Flat rate, dose-independent
- Third-party batch testing
- Care360 coaching included
Affiliate link. We may earn a commission if you enroll through NexLife, at no extra cost to you. It does not affect this ranking — see how we score providers.
05Is compounded GLP-1 legal in Connecticut in 2026?
Connecticut follows the same federal framework as the rest of the country: after the FDA resolved the semaglutide and tirzepatide shortages in 2025, broad compounding ended. Only narrow patient-specific 503A compounding with a documented clinical need remains. Read the full 2026 legal status explainer and our provider verification checklist before enrolling with any provider serving Connecticut.
Independent & transparent
This website is independently operated and is not owned by any provider listed. Some outbound links may be affiliate or sponsored links. Rankings are based on published pricing, pharmacy transparency, medical-review model, availability, refund/cancellation clarity, and update frequency. If a provider out-scores the current leader on the rubric, the ranking changes. See our methodology → · Who pays us →